RCMW — RCMW Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.70m
Annual income statement for RCMW, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2008 June 30th | 2009 June 30th | 2010 April 30th | 2011 April 30th | 2020 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 0 | 0 | 0.373 | 0.91 | 0 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.126 | 0.181 | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 0.326 | 0.133 | 0.899 | 3.82 | 0.354 |
Operating Profit | -0.326 | -0.133 | -0.527 | -2.91 | -0.354 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.326 | -0.133 | -0.597 | -2.66 | -0.354 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.326 | -0.133 | -0.597 | -2.66 | -0.354 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.326 | -0.133 | -0.574 | -2.65 | -0.354 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.326 | -0.133 | -0.574 | -2.65 | -0.354 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -9.88 | -4.04 | -17.4 | -47.6 | -0.078 |
Dividends per Share |